Replimune Group, Inc. (REPL)

8.07 +1.03 (+14.63%) USD  |  NASDAQ  |  Mar 06, 16:00
9.21 +1.14 (+14.13%) After-Hours: 20:00
More

Replimune Group Return on Invested Capital (3y Median)

Return on Invested Capital (3y Median) Chart

View Return on Invested Capital (3y Median) for REPL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Return on Invested Capital (3y Median) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Return on Invested Capital (3y Median) Range, Past 5 Years

View Return on Invested Capital (3y Median) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Return on Invested Capital (3y Median) Benchmarks

View Return on Invested Capital (3y Median) Benchmarks
Start Trial
Catalyst Pharmaceuticals, Inc. Upgrade
Sarepta Therapeutics, Inc. Upgrade
REGENXBIO, Inc. Upgrade
Bristol Myers Squibb Co. Upgrade
Mirum Pharmaceuticals, Inc. Upgrade